// App-Quantinova.ai

2596 : Hydroxychloroquine Use Is Associated with Decreased Dendritic Cell Activation and Thrombolytic Factors in SLE Patients

Researchers

Presenter

  • Samantha Slight-Webb

Principal Investigators

  • Rufei Lu

  • Hua Chen

  • Holden T. Maecker

  • Paul J. Utz

  • Joel M. Guthridge

  • Judith A. James

Medical Centers

  • Arthritis & Clinical immunology, OK Med Research Foundation, Oklahoma City, OK

  • Rheumatology, Oklahoma Medical Research Foundation, Oklahoma City, OK

  • Medicine/Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA

  • Stanford School of Medicine, Stanford, CA

  • Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City,, OK

  • Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City,, OK

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

  • Peripheral blood mononuclear cell

  • Phosphorylated signal transducer and activator of transcription 5

  • Phosphorylated-extracellular signal regulated kinase

  • Cluster of Differentiation 2AP

  • T-cell receptor

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved